GeoVax Sets October 27 Vote on Reverse Split and 11.4M-Share Warrant Exercise
GOVX is trading near its 52-week low of $0.45 (2.2% above the low).
Summary
GeoVax shareholders will vote October 27 on a reverse stock split to regain Nasdaq compliance and on issuing 11.4 million shares to an institutional investor for approximately $7.3 million in critical funding.
Key Events · Corporate Governance and Compliance · GOVX
-
Special Meeting Set for October 27
Shareholders of record as of August 28, 2026 will vote on two proposals: a reverse stock split and approval of a warrant exercise that could issue 11,395,256 shares.
-
Reverse Split to Regain Nasdaq Compliance
The Board seeks authority to implement a 1-for-10 to 1-for-25 reverse split to lift the stock price above Nasdaq's $1.00 minimum bid requirement after receiving a delisting notice on August 27, 2026.
-
Warrant Exercise Would Raise $7.3M
The August 2026 Warrant has an exercise price of $0.64 per share. Full exercise would generate approximately $7,292,964 in gross proceeds — critical given only $3.1 million in cash as of the last 10-Q.
-
Massive Dilution Risk
The 11,395,256 shares issuable upon warrant exercise represent approximately 55.6% of the post-exercise share count, though a 4.99% ownership blocker limits the investor's beneficial ownership at any single time.
Analysis · GOVX · Life Sciences
GeoVax is asking shareholders to approve two critical survival measures at a special meeting on October 27, 2026. The first is a reverse stock split of 1-for-10 to 1-for-25 to regain Nasdaq's $1.00 minimum bid price compliance after receiving a delisting notice. The second is approval to issue up to 11,395,256 shares upon exercise of a warrant held by an institutional investor, which would raise approximately $7.3 million in gross proceeds at $0.64 per share. With only $3.1 million in cash as of the last 10-Q and operations funded only into September 2026, this capital is essential for the company's survival. The warrant exercise would be highly dilutive — the 11.4 million shares represent approximately 55.6% of the post-exercise share count — but the alternative is running out of cash. The reverse split is the company's best remaining path to maintain its Nasdaq listing, though it carries no guarantee of success.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.6% of the 1805 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GOVX was trading at $0.46 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.2M. The 52-week trading range was $0.45 to $18.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.